The global market of Melatonin is witnessing a divergence in regional price dynamics as July **** progresses. The Asia-Pacific region is showing clear signs of decline, while North America which is led by the U.S. continues to maintain price stability. This contrast has caught the attention of market participants from excipient manufacturers to end-use formulation units.
The APAC suppliers are navigating through market oversupply and weak offtake. The North American exporters have maintained a balance between manufacturing output and sectoral demand. The global pharmaceutical excipient trade has, therefore, found itself in a complex yet predictable price environment which is driven by inventory rationalization and shifting buyer sentiment.
The Melatonin market has been under downward pressure in the Asia-Pacific region throughout the first half of July. The Chinese exporters have maintained uninterrupted production schedules that led to an accumulation of...
Leave a Comment
Comments (0)